secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2022-03-16T23:59:59+00:00
Accession:  0001193125-22-076869
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker appoints Philip Ma to board; director Marc Kastner to retire at 2023 meeting
--------------------------------------------------------------------------------

- Philip Ma appointed to board effective April 1, 2022, filling newly created Class II vacancy.
- Marc Kastner will retire and not stand for re-election at 2023 annual meeting; continues serving until then.
- Ma is CEO/founder of PrognomiQ, in which Bruker made $12M minority investment in February 2022.
- Ma's background includes multiomics, life science tools, and biopharma; will serve as non-employee director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000119312522076869/0001193125-22-076869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000119312522076869/d333656d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-076869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer